SHELLIE NORMAN: Open Payments
NPI 1841609971 · KAILUA KONA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 43 payments from 10 companies in 2025. Trend: 2023 $1,140 · 2024 $1,774 · 2025 $1,079
Food & beverage: $1,030Education: $48
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $408 |
| Amgen Inc. | 5 | $183 |
| Regeneron Healthcare Solutions, Inc. | 4 | $178 |
| Janssen Biotech, Inc. | 3 | $87 |
| Galderma Laboratories, L.P. | 3 | $59 |
| UCB, Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 3 | $46 |
| Lilly USA, LLC | 1 | $28 |
| Organon LLC | 1 | $25 |
| REVANCE THERAPEUTICS, INC. | 1 | $18 |
Products named: OTEZLA, DUPIXENT, SKYRIZI, BOTOX, TREMFYA, RINVOQ, Bimzelx, Sotyktu.
Industry payments across HI — which companies pay providers there.
